Literature DB >> 28835744

Depression and Age at First Neurology Appointment Associated with Receipt of Behavioral Medicine Services Within 1 Year in a Multiple Sclerosis Population.

Benjamin Greenberg, Youran Fan, Lucille Carriere, Amy Sullivan.   

Abstract

BACKGROUND: Patients with multiple sclerosis (MS) newly seen by a neurologist may benefit from early psychological intervention owing to the reciprocal relationship between stress and disease progression. However, it is uncertain what factors contribute to patients' receiving these services.
METHODS: Logistic regression analysis of prospectively gathered data evaluated how demographic and disease characteristics and emotional/physical health factors contributed to referral to receive behavioral medicine (BM) services within 1 year of their first neurology appointment at the Mellen Center for Multiple Sclerosis at the Cleveland Clinic. Survival analyses then evaluated whether this resulted in earlier receipt of services.
RESULTS: Although many factors were associated with receiving BM services during univariate analyses (age, race, marital status, years since MS onset, depression, stress, and quality of life), when considering multivariable interactions, only two variables remained significant: age (odds ratio [OR] = 0.86, 95% confidence interval [CI], 0.80-0.92) and depression (OR = 1.56, 95% CI, 1.39-1.75). Survival analyses did not show differences in time to BM services for stratifications of age or depression scores.
CONCLUSIONS: Younger patients and patients with more severe depression were more likely to receive BM services within 1 year of their first neurology appointment. Future research will focus on evaluating whether these are also the patients in greatest need of services or whether they are simply more open to receiving them.

Entities:  

Year:  2017        PMID: 28835744      PMCID: PMC5564281          DOI: 10.7224/1537-2073.2016-012

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  32 in total

Review 1.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

2.  Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample.

Authors:  Lydia Chwastiak; Dawn M Ehde; Laura E Gibbons; Mark Sullivan; James D Bowen; George H Kraft
Journal:  Am J Psychiatry       Date:  2002-11       Impact factor: 18.112

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 4.  Cognitive-behavioral therapy: what benefits can it offer people with multiple sclerosis?

Authors:  Laura Dennison; Rona Moss-Morris
Journal:  Expert Rev Neurother       Date:  2010-09       Impact factor: 4.618

5.  Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.

Authors:  Kirsten Sjonnesen; Sandy Berzins; Kirsten M Fiest; Andrew G M Bulloch; Luanne M Metz; Brett D Thombs; Scott B Patten
Journal:  Postgrad Med       Date:  2012-09       Impact factor: 3.840

6.  Autonomic dysfunction in multiple sclerosis: correlation with disease-related parameters.

Authors:  Dilek I Gunal; Nazire Afsar; Tulin Tanridag; Sevinc Aktan
Journal:  Eur Neurol       Date:  2002       Impact factor: 1.710

7.  Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group.

Authors:  C E Schwartz; T Vollmer; H Lee
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

8.  The Pain Disability Index: psychometric and validity data.

Authors:  R C Tait; C A Pollard; R B Margolis; P N Duckro; S J Krause
Journal:  Arch Phys Med Rehabil       Date:  1987-07       Impact factor: 3.966

9.  Validity of performance scales for disability assessment in multiple sclerosis.

Authors:  R A Marrie; M Goldman
Journal:  Mult Scler       Date:  2007-07-10       Impact factor: 6.312

10.  A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue.

Authors:  Kirsten van Kessel; Rona Moss-Morris; Ernest Willoughby; Trudie Chalder; Malcolm H Johnson; Elizabeth Robinson
Journal:  Psychosom Med       Date:  2008-02-06       Impact factor: 4.312

View more
  2 in total

1.  Effects of Conformity to Masculine Norms and Coping on Health Behaviors in Men With Multiple Sclerosis.

Authors:  Bryan Davis; Ryan Honomichl; Amy B Sullivan
Journal:  Int J MS Care       Date:  2022-03-14

Review 2.  Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives.

Authors:  Elisabeth G Celius; Heidi Thompson; Maija Pontaga; Dawn Langdon; Alice Laroni; Stanca Potra; Trishna Bharadia; David Yeandle; Jane Shanahan; Pieter van Galen; Nektaria Alexandri; Jürg Kesselring
Journal:  Patient Prefer Adherence       Date:  2021-01-08       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.